Stelzer Laurie
CIK: 0001644348•CFO
OfficerDirector
Primary company: HALOZYME THERAPEUTICS, INC. (HALO)
Stelzer Laurie is a corporate insider (CFO) at HALOZYME THERAPEUTICS, INC. (HALO) filing SEC Form 4 transactions. 89 transactions across 7 companies, totaling $172,384 in purchases and $172,218 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 17,340 | $36.73 | $637K | 17,340 | 6/17/2026 Filed: 6/17/2026 | Filing → | |
| Award | 12,500 | $30.91 | $386K | 12,500 | 6/4/2026 Filed: 6/4/2026 | Filing → | |
| Award | 8,026 | $72.51 | $582K | 8,026 | 5/27/2026 Filed: 5/27/2026 | Filing → | |
| Award | 19,959 | - | - | 19,959 | 6/12/2025 Filed: 6/16/2025 | Filing → | |
| Award | 33,500 | - | - | 33,500 | 6/5/2025 Filed: 6/9/2025 | Filing → | |
| Award | 25,000 | - | - | 25,000 | 5/29/2025 Filed: 6/2/2025 | Filing → | |
| Award | 67,500 | - | - | 67,500 | 6/6/2024 Filed: 6/10/2024 | Filing → | |
| Award | 11,323 | - | - | 11,323 | 5/14/2024 Filed: 5/16/2024 | Filing → | |
Spyre Therapeutics, Inc. AGLE | Award | 50,000 | $0.00 | $0 | 50,000 | 11/22/2023 Filed: 11/27/2023 | Filing → |
Mirati Therapeutics, Inc. MRTX | Award | 22,297 | $37.00 | $825K | 102,312 | 8/9/2023 Filed: 8/10/2023 | Filing → |
| Award | 21,500 | $0.00 | $0 | 21,500 | 6/8/2023 Filed: 6/12/2023 | Filing → | |
Mirati Therapeutics, Inc. MRTX | Sale | 4,647 | $37.06 | $172K | 80,015 | 6/2/2023 Filed: 6/2/2023 | Filing → |
Mirati Therapeutics, Inc. MRTX | Award | 45,456 | $0.00 | $0 | 45,456 | 1/20/2023 Filed: 1/24/2023 | Filing → |
Mirati Therapeutics, Inc. MRTX | Award | 26,864 | $0.00 | $0 | 84,662 | 1/20/2023 Filed: 1/24/2023 | Filing → |
Surface Oncology, Inc. SURF | Award | 24,000 | $0.00 | $0 | 24,000 | 6/8/2022 Filed: 6/10/2022 | Filing → |
| Award | 19,500 | $0.00 | $0 | 19,500 | 6/2/2022 Filed: 6/6/2022 | Filing → | |
Mirati Therapeutics, Inc. MRTX | Award | 91,164 | $0.00 | $0 | 91,164 | 6/1/2022 Filed: 6/3/2022 | Filing → |
Mirati Therapeutics, Inc. MRTX | Award | 57,798 | $0.00 | $0 | 57,798 | 6/1/2022 Filed: 6/3/2022 | Filing → |
ARENA PHARMACEUTICALS INC ARNA | Disposition | 15,200 | - | - | 0 | 3/11/2022 Filed: 3/11/2022 | Filing → |
ARENA PHARMACEUTICALS INC ARNA | Disposition | 38,850 | - | - | 0 | 3/11/2022 Filed: 3/11/2022 | Filing → |
Type
Award
Shares
17,340
Price
$36.73
Value
$637K
Type
Award
Shares
12,500
Price
$30.91
Value
$386K
Type
Award
Shares
8,026
Price
$72.51
Value
$582K
Type
Award
Shares
19,959
Price
-
Value
-
Type
Award
Shares
33,500
Price
-
Value
-
Type
Award
Shares
25,000
Price
-
Value
-
Type
Award
Shares
67,500
Price
-
Value
-
Type
Award
Shares
11,323
Price
-
Value
-
Spyre Therapeutics, Inc.
AGLE
Type
Award
Shares
50,000
Price
$0.00
Value
$0
Mirati Therapeutics, Inc.
MRTX
Type
Award
Shares
22,297
Price
$37.00
Value
$825K
Type
Award
Shares
21,500
Price
$0.00
Value
$0
Mirati Therapeutics, Inc.
MRTX
Type
Sale
Shares
4,647
Price
$37.06
Value
$172K
Mirati Therapeutics, Inc.
MRTX
Type
Award
Shares
45,456
Price
$0.00
Value
$0
Mirati Therapeutics, Inc.
MRTX
Type
Award
Shares
26,864
Price
$0.00
Value
$0
Surface Oncology, Inc.
SURF
Type
Award
Shares
24,000
Price
$0.00
Value
$0
Type
Award
Shares
19,500
Price
$0.00
Value
$0
Mirati Therapeutics, Inc.
MRTX
Type
Award
Shares
91,164
Price
$0.00
Value
$0
Mirati Therapeutics, Inc.
MRTX
Type
Award
Shares
57,798
Price
$0.00
Value
$0
ARENA PHARMACEUTICALS INC
ARNA
Type
Disposition
Shares
15,200
Price
-
Value
-
ARENA PHARMACEUTICALS INC
ARNA
Type
Disposition
Shares
38,850
Price
-
Value
-
AI Agent
Try asking...